rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to evaluate the safety and characteristics of live, recombinant viral vector vaccines. A recent publication by the V3SWG described live, attenuated, recombinant vesicular stomatitis virus (rVSV) as a chimeric vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Monath, Thomas P., Fast, Patricia E., Modjarrad, Kayvon, Clarke, David K., Martin, Brian K., Fusco, Joan, Nichols, Richard, Heppner, D. Gray, Simon, Jakub K., Dubey, Sheri, Troth, Sean P., Wolf, Jayanthi, Singh, Vidisha, Coller, Beth-Ann, Robertson, James S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Brighton Collaboration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668225/
https://www.ncbi.nlm.nih.gov/pubmed/31384731
http://dx.doi.org/10.1016/j.jvacx.2019.100009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668225/
https://www.ncbi.nlm.nih.gov/pubmed/31384731
http://dx.doi.org/10.1016/j.jvacx.2019.100009

Ejemplares similares